Answers are grounded in this paper and cite their sources.
Semi-synthesized HDL2 AI can serve as a reliable primary standard for evaluating serum apo AI levels, which appear lower in patients with ischemic heart disease and cerebral thrombosis.
In order to get the ideal standard substance to evaluate serum apo AI in geriatric patients such as IHD and cerebral thrombosis, HDL2 AI was semi synthesized with purely separated apo AI, lecithin and lysolecithin by urtrasonic synthesis method.The properties of this semi-synthesized HDL2 AI was strictly examined by CD spectrum, zone electrophoresis, lipo-dyed microultracentifugation method and immunoelectrophoresis and found to be identical to serum HDL2 AI.By using semi-synthesized HDL2 AI as primary standard, apo AI value in QS serum (lyphilized pooled fresh Japanese serum by more than 3000 healthy people) was standardized as 108±6mg/dl, and the serum from 19 patients (9 cerebral thrombosis, 3 IHD and others) were evaluated by this standard value, which showed fairly lower value.These results suggest that semi-synthesized HDL2 AI can be used for the evaluation of the clinical meanings of apo A, apo AI in the patients of IHD and cerebral thrombosis.
No takes yet. Share an insight, caveat, or question.
Sanuki et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: